Victoria Villaflor, M.D. is board-certified medical oncologist specializing in upper aerodigestive tract malignancies, including head and neck and thoracic malignancies.  She is a Professor and Section Chief for Head & Neck Oncology in the Department of Medical Oncology and Therapeutics Research at City of Hope in Duarte, California.  Dr. Villaflor has over 18 years of experience in leading clinical trials, translational science and working in multidisciplinary teams.

Her background is in microbiology and immunology and her primary interests are focused on improving patient survival and improving outcomes.  She has led numerous studies to optimize chemoradiotherapy and improve outcomes.  Additionally, she has developed and lead multiple novel clinical trials focused on oncogene exploitation and immunomodulatory approaches for upper aerodigestive malignancies.  She has vast experience in translational science.  Her team was the first to publish on the use of circulating tumor DNA in lung cancer patients.  She has led efforts in characterization of molecular targets on outcomes following surgery.  She has worked with scientists evaluating the role of IDO-1 in outcomes of esophageal cancer patients.  She is most passionate in personalized therapies and how to best optimize their use in clinical practice to ultimately improve both survival and toxicity outcomes in patients.

Dr. Villaflor has extensive experience and has served on many international grant and research committees.  She has been a member of the scientific committee and IRB.  She has served as a reviewer for numerous journals.  She has served on international education committees.